tm logo
ELUVOGUE
REGISTERED

on 24 Aug 2021

Last Applicant/ Owned by

ABBVIE BIOTECHNOLOGY LTD.

4th Floor, Washington House16 Church StreetHamilton HM 11

BM

Serial Number

1922991 filed on 01st Oct 2018

Registration Number

TMA1107428 registered on 24th Aug 2021

Registration expiry Date

24th Aug 2031

Correspondent Address

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

ELUVOGUE

Trademark usage description

pharmaceutical preparations for the treatment of viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome (aids); pharmaceutical Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome (AIDS); pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of cardiovascular and cardiopulmonary diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, incontinence, inflammatory pelvic diseases and sexual dysfunction; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of ophthalmic, respiratory and gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Parkinson's, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment and prevention of migraines, headaches and pain.


Classification kind code

11

Mark Details


Serial Number

1922991

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 11th Aug 2021
Registration Pending
Submitted for opposition 42
on 19th May 2021
Advertised
Submitted for opposition 135
on 06th May 2021
Amendment to Application
Submitted for opposition 26
on 29th Mar 2021
Approved
Submitted for opposition 27
on 29th Mar 2021
Approval Notice Sent
Submitted for opposition 22
on 21st Dec 2020
Search Recorded
Submitted for opposition 20
on 21st Dec 2020
Examiner's First Report
Submitted for opposition 31
on 04th Oct 2018
Formalized
Submitted for opposition 1
on 02th Oct 2018
Created
Submitted for opposition 30
on 01st Oct 2018
Filed